Invention Grant
US09266813B2 Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof
有权
扁桃体化合物作为鳞状细胞癌和肝癌的抑制剂及其用途
- Patent Title: Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof
- Patent Title (中): 扁桃体化合物作为鳞状细胞癌和肝癌的抑制剂及其用途
-
Application No.: US14229339Application Date: 2014-03-28
-
Publication No.: US09266813B2Publication Date: 2016-02-23
- Inventor: Sheng-Chu Kuo , Jai-Sing Yang , Min-Tsang Hsieh , Tian-Shung Wu , Kuo-Hsiung Lee , Huei-Wen Chen , Li-Jiau Huang , Hsin-Yi Hung , Tzong-Der Way , Ling-Chu Chang , Hui-Yi Lin , Yung-Yi Cheng , Chin-Yu Liu
- Applicant: AnnCare Bio-Tech Center Inc.
- Applicant Address: TW Taichung
- Assignee: China Medical University
- Current Assignee: China Medical University
- Current Assignee Address: TW Taichung
- Agency: WPAT, P.C.
- Agent Anthony King
- Main IPC: A01N43/32
- IPC: A01N43/32 ; A61K31/335 ; C07D319/06 ; C07C69/00 ; C07C69/712 ; C07C69/675 ; C07C67/30 ; C07D407/04
Abstract:
The present invention provides a series of derivatives of stilbenoid which are useful as new inhibitory agents against head and neck squamous cell carcinoma (HNSCC) and hepatoma.
Public/Granted literature
- US20140303241A1 STILBENOID COMPOUND AS INHIBITOR FOR SQUAMOUS CARCINOMA AND HEPATOMA AND USES THEREOF Public/Granted day:2014-10-09
Information query
IPC分类:
